Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2018

Pharma News, 2018

FDA hits Mexican drugmaker Degasa with warning letter
FDA hits Mexican drugmaker Degasa with warning letter
The FDA issued a warning letter to Mexican finished-pharmaceutical manufacturer Degasa for issues including misbranding, failing to conduct adequate testing and problems with its water system.
Teva reports jump in first-quarter earnings, raises guidance
Teva reports jump in first-quarter earnings, raises guidance
AP — Israeli generic drug maker Teva Pharmaceutical Industries on Thursday said first-quarter earnings surged over 80 percent and raised its outlook for the rest of the year, citing progress in an a...
BeneVir to be bought by Janssen for up to $1.04 billion
BeneVir to be bought by Janssen for up to $1.04 billion
Privately-held USA-based biotech BeneVir has entered into a definitive agreement to be acquired by Janssen Biotech, part of US healthcare giant Johnson & Johnson (NYSE.
Could this common diabetes drug prevent cocaine relapse?
Could this common diabetes drug prevent cocaine relapse?
A recent study suggests that drugs already approved to treat obesity and type 2 diabetes might also help to treat cocaine addiction by reducing relapse.
From painkillers to cortisone injections: Scientists rank the five most effective treatments for knee osteoarthritis
From painkillers to cortisone injections: Scientists rank the five most effective treatments for knee osteoarthritis
Scientists have ranked the five most effective, non-surgical treatments for knee osteoarthritis (OA).
Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma
Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma
Basel, May 1, 2018 - Novartis today announced the US Food and Drug Administration (FDA) has approved Kymriah® (tisagenlecleucel) suspension for intravenous infusion for its second ...
United Therapeutics To Acquire SteadyMed Ltd.
United Therapeutics To Acquire SteadyMed Ltd.
SILVER SPRING, Md.
Cancer drug helps treat tuberculosis by restoring leaky blood vessels
Cancer drug helps treat tuberculosis by restoring leaky blood vessels
Biomedical engineers have discovered an unlikely potential ally in the global fight against tuberculosis—an FDA-approved drug originally designed to treat cancer.
Could vitamin A derivative cure liver cancer?
Could vitamin A derivative cure liver cancer?
Researchers shed light on how a synthetic form of vitamin A could help to eradicate liver cancer.
Global study finds 44 genetic risk factors for major depression
Global study finds 44 genetic risk factors for major depression
LONDON (Reuters) - International scientists have identified 44 genetic variants that can increase the risk of developing major depression and found that all humans carry at least some of them.
New study shows life-saving outcomes using 3-D printing models for heart valve disease
New study shows life-saving outcomes using 3-D printing models for heart valve disease
SAN DIEGO, APRIL 26, 2018 - A new study examines the effectiveness of 3D printing technology and computer modeling to predict paravalvular leak (PVL) in patients undergoing transcatheter aorti...
Twice rejected by Lilly, Adocia mounts recovery with diabetes drug deal
Twice rejected by Lilly, Adocia mounts recovery with diabetes drug deal
Adocia has sold the Chinese rights to two diabetes prospects to Tonghua Dongbao Pharmaceuticals for $50 million (€41 million) upfront.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand